Overview
Join a New Local Obesity Clinical Research Study
This Obesity Clinical Research Study is looking at an investigational oral study drug (tablet) to lower body weight in people living with obesity or overweight and weight-related conditions. Overweight and obesity are complex, chronic health conditions that impact Type 2 diabetes (T2D) and can be caused by several factors including genetics, environment, and hormones. Developing potential new treatments can offer people living with weight-related conditions like T2D more options that are better suited to their individual needs.
Table of Contents
About this Study
The purpose of this obesity clinical research study is to help answer important questions about an investigational medication, such as if it works, what dose may work best, and how safe it is. All medications must be researched in clinical research studies before they can be approved to prescribe to patients. Without people taking part in these studies, there would be no new medications.
This study is researching new ways to help adults lose weight and improve overall health. Being overweight or living with obesity can increase the risk of health conditions such as high blood pressure, high triglycerides, and type 2 diabetes.
Researchers are studying an oral medication to see whether it may help people with overweight or obesity manage their weight more effectively. The study will evaluate whether this medication is safe and how well it works when taken by adults who have weight-related health conditions.
The goal of the study is to learn whether this investigational medication may become a safe and effective option to support weight loss and improve health outcomes for adults living with obesity or overweight.
The study team or your study doctor will explain what this means for you in detail.
Who Can Join
People who may be able to take part in the Obesity Clinical Research Study must meet the following inclusion criteria:
-
Be 18–75 years of age
-
Have obesity or are overweight\
- Have at least one related health condition, such as:
- High blood pressure
- High triglycerides
- Type 2 diabetes
- Have tried to lose weight through diet and exercise within the past 6 months without success
- Participants must also have a BMI of at least 27
You may not be eligible if you:
- Have used weight loss medications, injections, or supplements within the past 3 months
- Take certain medications that may affect blood sugar, mood, or appetite
- Use systemic steroid medications
- Regularly use marijuana
Not sure if you qualify?
A member of our study team will review your medical history and medications with you to determine if this study may be a good fit for you.
You may also qualify for other studies.
What to Expect
If you decide to participate, you can expect the following during the obesity clinical research study:
Study Duration:
The study will last about 46 weeks to 1 year.
Study Visits:
You will regularly meet with a nutritional professional and study staff for study-related care.
Up to 16 visits
Medication:
You will take the study drug (or placebo) once daily in tablet form.
Participants:
About 320 participants will join this study globally.
Compensation:
Compensation may be available for your reasonable time and travel costs. To be discussed.
More Details
If you have any other questions about what to expect from the study, feel free to ask the study team or your study doctor.